12 insiders have filed at IMNM since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Barchas Isaac | Director | 4.17M | 3.682% | 2 sells $8.3M | |
| Rapp Michael | Director | 1.28M | 1.131% | ||
| Siegall Clay B | President And CEO | 690.7k | 0.611% | 11 buys $7.3M | |
| Wagenheim Philip | Director | 341.1k | 0.302% | 2 sells $1.3M | |
| Prendergast Franklyn G | Director | 60.8k | 0.054% | ||
| Rosett Max | Chief Financial Officer | 47.5k | 0.042% | 1 sells $230k | |
| Tsai Philip | Chief Technical Officer | 43.3k | 0.038% | 3 buys $506k | |
| Turner Bruce | Chief Strategy Officer | 42.3k | 0.037% | 1 buys $250k | |
| Higgins Jack | Chief Scientific Officer | 40.7k | 0.036% | 1 sells $49k | |
| Bienaime Jean Jacques | Director | 38.4k | 0.034% | 7 buys $333k | |
| Lechleider Robert | Chief Medical Officer | 15.8k | 0.014% | 1 buys $150k | |
| Lapetina Bob | Pao And VP Finance & Corporate | 12.0k | 0.011% |
Full register at boothcheck.com/insiders/IMNM. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.